Page 100 - AN-3-1
P. 100

Advanced Neurology                                               Neurological adverse events post-vaccination




             A                                               B



















            C




















            Figure 5. Autism spectrum disorder yearly normalized frequencies for (A) polio virus, inactivated; (B) measles, mumps, and rubella; and (C) Haemophilus
            B conjugate vaccine. The charts were developed based on Vaccine Adverse Events Reporting System data from 1990 to November 3, 2023.

            •   Compared to influenza, the ASD day 0 normalized   4. Discussion
               frequency is enriched for 25 vaccines; some     4.1. Neurological AEs post-vaccination
               immunizations may act like a trigger event for ASD,
               similar  to  that  for  Dravet  syndrome,  for  vaccinees   Multiple vaccines exhibited different patterns of
               with preexisting genetic risk factors.          neurological AEs post-immunization (Figure 1). Syncope
            •   The current population ASD frequency can be aligned   and autoimmune diseases (complex regional pain syndrome
               with the combined frequencies reported to VAERS for   [CRPS], postural orthostatic tachycardia syndrome
               recommended infant vaccines.                    [POTS], and chronic fatigue syndrome [CFS]) post-HPV
            •   For infants less than 12 months of age, delaying MMR   vaccination have been previously noted in a cluster analysis
               immunization until the recommended age of 12 –   of reports in VigiBase.  Post-marketing surveillance of
                                                                                  52
               15 months is predicted to reduce AEs in aphasia, ASD,   AEs following meningococcal B vaccination reported
               neurological disorder, and speech disorder.     low frequencies of  AEs following  immunization with
            •   While  excipients  may  vary  between  different   the majority of serious AEs reported in 2- to 11-month-
                                                                         53
               individual vaccines for the same target pathogens   old children.  As demonstrated for Dravet syndrome,
                                                                                                           4,36
               and can be modified over time, the results (Figure 5)   immunization may trigger AEs in children with genetic risk
               might also be consistent with possible manufacturing   factors like those reported by Charzewska et al. 38
               contaminant(s) (e.g., endotoxins ) (with possible
                                           51
               overlaps between unrelated vaccines) associated with   4.2. COVID-19 and influenza vaccines
               AEs.                                            In the case of the COVID-19 vaccine, these retrospective
            •   Seizure AEs have higher normalized frequencies   results (Figure 3 and Table S3) support a causal relationship
               across all of the vaccines summarized herein.   between COVID-19 vaccines and adverse neurological


            Volume 3 Issue 1 (2024)                         7                         https://doi.org/10.36922/an.2258
   95   96   97   98   99   100   101   102   103   104   105